Literature DB >> 1068629

Experimentally developed cellular resistance to daunomycin. Resistance mechanisms, the daunomycin-pump and cross resistance to adriamycin, vincristine and vinblastine.

K Dano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1068629

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand Suppl


× No keyword cloud information.
  8 in total

1.  Cross resistance and cellular uptake of 4'-O-methyldoxorubicin in experimental tumors with acquired resistance to doxorubicin.

Authors:  A Di Marco; T Skovsgaard; A M Casazza; G Pratesi; N I Nissen; K Danø
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

2.  Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines.

Authors:  K Häussermann; B Benz; V Gekeler; K Schumacher; M Eichelbaum
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells. Determination by high pressure liquid chromatography.

Authors:  D Londos-Gagliardi; R Baurain; J Robert; G Aubel-Sadron
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

4.  DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression.

Authors:  P G Debenham; N Kartner; L Siminovitch; J R Riordan; V Ling
Journal:  Mol Cell Biol       Date:  1982-08       Impact factor: 4.272

5.  Persistence of colchicine resistance in Ehrlich-Lettré ascites tumors and cell strains.

Authors:  C Granzow
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

6.  Analysis of heterogeneity in daunorubicin uptake by human leukemia cells using laser flow cytometry.

Authors:  R Ganapathi; P Gulick; R Miller; D Grabowski; R Turinic; R Valeunzuela; A Fishleder; R Bukowski
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

7.  Detection of induced resistance in short-term-tests. Adriamycin-resistant sarcoma 180.

Authors:  M Volm; C Lindner
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-01-26

8.  Decreased autolysis of dead cells in adriamycin-resistant lines of the sarcoma 180 of mouse.

Authors:  J Sonka; A Günther; M Volm
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.